Watsonia North, Australia

Damian Wojciech Grobelny


 

 

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 74(Granted Patents)


Location History:

  • Victoria, AU (1999)
  • Watsonja North, AU (2001)
  • Watsonia, AU (2012)
  • Watsonia North, AU (1997 - 2019)

Company Filing History:


Years Active: 1997-2019

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Damian Wojciech Grobelny: A Pioneer in Pharmaceutical Innovations

Introduction

Damian Wojciech Grobelny, located in Watsonia North, Australia, is a prolific inventor known for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 19 patents, Grobelny has made notable strides in the development of compounds with therapeutic potential.

Latest Patents

Among his recent inventions are several cutting-edge patents. One such patent involves substituted benzofurans, benzothiophenes, benzoselenophenes, and indoles, focusing on their application as tubulin polymerization inhibitors. This work holds promise for advancements in treating various conditions related to cell growth and division. Additionally, Grobelny has developed novel compounds that act as S1P receptor modulators. This invention not only entails the discovery of these compounds but also includes their use in pharmaceuticals aimed at addressing autoimmune responses linked to inappropriate S1P receptor activity. The dual focus on drug formulation and application underscores his dedication to addressing critical healthcare challenges.

Career Highlights

Throughout his career, Grobelny has worked with reputable organizations, including Bionomics Inc. and Narhex Limited. His experience in these companies has helped shape his innovative work, allowing him to merge scientific research with practical applications in the pharmaceutical sector.

Collaborations

Collaboration has been a key aspect of Grobelny's journey as an inventor. He has closely worked with notable colleagues such as Bernard Luke Flynn and Jason Hugh Chaplin. Their collective efforts have significantly contributed to the advancement of their respective fields and have fostered a spirit of innovation and creativity.

Conclusion

Damian Wojciech Grobelny exemplifies the spirit of innovation in the pharmaceutical industry. With his impressive record of patents and collaborative efforts, he continues to pave the way for new developments that can impact healthcare positively. His work stands as a testament to the power of invention in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…